Stockreport

Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Candel Therapeutics, Inc.  (CADL) 
PDF NEEDHAM, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused [Read more]